Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-15
2005-11-15
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S217040, C514S218000, C514S228200, C514S253040, C514S301000, C540S492000, C540S544000, C540S575000, C540S597000, C544S060000, C544S362000, C546S114000
Reexamination Certificate
active
06964956
ABSTRACT:
Disclosed are compounds of formula (I):wherein R1and R2are defined herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
REFERENCES:
patent: 5656638 (1997-08-01), Gaeta et al.
patent: 6232320 (2001-05-01), Stewart et al.
patent: 6313301 (2001-11-01), Miki et al.
patent: 6579882 (2003-06-01), Stewart et al.
patent: 2001/0020030 (2001-09-01), Stewart et al.
patent: WO 92/03427 (1992-03-01), None
patent: WO 00/61586 (2000-10-01), None
patent: WO 00/75145 (2000-12-01), None
patent: WO 01/30774 (2001-05-01), None
patent: WO 01/58890 (2001-08-01), None
patent: WO 01/68648 (2001-09-01), None
patent: WO 03/037886 (2003-05-01), None
patent: WO 01/00610 (2004-01-01), None
Kadushkin et al. Khimiko-Farmatsevticheskii Zhurnal (1992), 26(11-12): 62-6.
Albert S. Baldwin, Jr., The NF-kB and IkB Proteins: New Discoveries and Insights, Annu. Rev. Immunol. 1996, 14: 649-681.
Toshiki Murata, et al, Discovery of Novel and Selective IKK-B Serine-Threonine Protein Kinase Inhibitors. Part 1, Bioorganic & Medicinal Chem Letters, 2003 13:913-918 Elsevier Science Ltd.
XP-002254095 Abstract, “Synthesis of Novel Heterocyclic Compounds for Antitumor and Radioprotective Activities”.
M.-M. Ghorab, et al., “Synthesis of Novel Heterocyclic Compounds for Antitumor and Radioprotective Activities”, Phosphorus, Sulfur, and Silicon, 1998 vol. 134/135, pp 447-462.
XP-002254099 Abstract, “Use of benzo- and pyrido-furan or -thiophene cpds.—as hypercalcaemia agents for treating osteoporosis”.
XP-002254097 Abstract, “Synthesis and Antimicrobial Evaluation of Several New Pyridine, Thienopyridine and Pyridothienopyrazole Derivatives”.
F.A. Attaby, et al., “Synthesis and Antimicrobial Evaluation of Several New Pyridine, Thienopyridine and Pyridothienopyrazole Derivatives”, Phosphorus, Sulfur, and Silicone, 1999, vol. 149, pp. 49-64.
E.I. Kaigorodova, et al., “Synthesis of Substituted 2-Alkyl(Aryl)Thio-3-Cyanopyridines and 3-Aminothieno[2,3-b] Pyridines”, Chem. Heterocyclic Compounds, vol. 32, No. 10, pp. 1234-1238 1996.
G. Wagner, et al., “Synthese neuer prim., sek. und tert. 3-Amino-thieno[2,3-b]pyridin-2-carbonsaureamide auf verschiedenen Wegen”, vol. 45, 1990, pp. 102-109.
Chen Zhidong
Cywin Charles L.
Emeigh Jonathan
Fleck Roman Wolfgang
Hao Ming-Hong
Boehringer Ingelheim Pharmaceuticals Inc.
Devlin Mary-Ellen M.
Dow David A.
Huang Evelyn Mei
Morris Michael
LandOfFree
Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3477399